Biotech Stocks
Court halts Colorado price cap on Amgen's blockbuster Enbrel
Endpoints News
6h ago
70% Move
US District Court Judge Daniel Domenico in Colorado granted Amgen's preliminary injunction to stop a 70% price cap on its blockbuster autoimmune drug Enbrel, arguing that the cap could cause "economic injury" to the company ...
Discussion
Sign in to join the discussion. Comments loading…